Literature DB >> 19939365

Creation of a neovagina after Creatsas modification of Williams vaginoplasty for the treatment of 200 patients with Mayer-Rokitansky-Kuster-Hauser syndrome.

George Creatsas1, Efthimios Deligeoroglou, Panagiotis Christopoulos.   

Abstract

OBJECTIVE: To present and evaluate the results of the Creatsas modification of Williams vaginoplasty for the creation of a neovagina in young women with Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome.
DESIGN: Retrospective study.
SETTING: Division of Pediatric-Adolescent Gynecology and Reconstructive Surgery, Second Department of Obstetrics and Gynecology, University of Athens, Aretaieion Hospital, Athens, Greece. PATIENT(S): Two hundred patients with the MRKH syndrome. INTERVENTION(S): Clinical examination, pelvic ultrasound, intravenous urography and/or renal ultrasound, laparoscopy, karyotyping, orthopedics and ears, nose, and throat examination, magnetic resonance imaging, and Creatsas modification of Williams vaginoplasty. MAIN OUTCOME MEASURE(S): Neovaginal functional dimentions, neovaginal axis deviation, and quality of sexual life. RESULT(S): A functioning vagina of 10-12 cm in depth and 5 cm in width was created in 191 cases (95.5%). A vagina between 7 and 9 cm in depth and 2 and 3 cm in width was created for the remaining nine patients (4.5%). In addition, 94.5% declared themselves to have a satisfactory quality of sexual life, while only 5% of the cases reported an adequate one. CONCLUSION(S): Creatsas modification of Williams vaginoplasty is a simple, quick, and effective method for the treatment of vaginal agenesis.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19939365     DOI: 10.1016/j.fertnstert.2009.09.064

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

Review 1.  Dilation and surgical management in vaginal agenesis: a systematic review.

Authors:  Sarah K McQuillan; Sonia R Grover
Journal:  Int Urogynecol J       Date:  2013-10-10       Impact factor: 2.894

2.  Reconstruction of congenital defects of the vagina.

Authors:  Liron Eldor; Jeffrey D Friedman
Journal:  Semin Plast Surg       Date:  2011-05       Impact factor: 2.314

Review 3.  Systematic review of sexual function and satisfaction following the management of vaginal agenesis.

Authors:  Sarah K McQuillan; Sonia R Grover
Journal:  Int Urogynecol J       Date:  2014-02-15       Impact factor: 2.894

4.  Sexual satisfaction in patients with Mayer-Rokitansky-Küster-Hauser syndrome after surgical and non-surgical techniques: a systematic review.

Authors:  Sahar Dabaghi; Mitra Zandi; Mahnaz Ilkhani
Journal:  Int Urogynecol J       Date:  2019-01-05       Impact factor: 2.894

5.  Consensus in Guidelines for Evaluation of DSD by the Texas Children's Hospital Multidisciplinary Gender Medicine Team.

Authors:  Ganka Douglas; Marni E Axelrad; Mary L Brandt; Elizabeth Crabtree; Jennifer E Dietrich; Shannon French; Sheila Gunn; Lefkothea Karaviti; Monica E Lopez; Charles G Macias; Laurence B McCullough; Deepa Suresh; V Reid Sutton
Journal:  Int J Pediatr Endocrinol       Date:  2010-10-17

6.  Primary amenorrhea in adolescent girls: normal coitus or not? Always take a look in the physician's office.

Authors:  Flora Bacopoulou; George Creatsas; George P Chrousos; Nikoleta Papanikolaou; Efthimios Deligeoroglou
Journal:  BMC Womens Health       Date:  2014-02-10       Impact factor: 2.809

7.  Clinical pilot study to evaluate the neovaginal PACIENA prosthesis® for vaginoplasty without skin grafts in women with vaginal agenesis.

Authors:  Pedro Acién; Francisco J Nohales-Alfonso; Maria-Luisa Sánchez-Ferrer; Miguel Sánchez-Lozano; Victoria Navarro-Lillo; Maribel Acién
Journal:  BMC Womens Health       Date:  2019-11-26       Impact factor: 2.809

Review 8.  Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome: a comprehensive update.

Authors:  Morten Krogh Herlin; Michael Bjørn Petersen; Mats Brännström
Journal:  Orphanet J Rare Dis       Date:  2020-08-20       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.